The Prevalence of Concomitant Skip Small Bowel Lesions in Crohn’s Disease and Their Effects on Reoperation in Patients Undergoing Ileocolic Resection
暂无分享,去创建一个
Lei Gao | Weiming Zhu | Zhen Guo | Yi Li | J. Gong | Lei Cao | Wenwei Qian | Liangyu Huang
[1] J. Leighton,et al. Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease Patients. , 2021, Inflammatory bowel diseases.
[2] S. Travis,et al. Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn’s Disease? , 2019, Diseases of the colon and rectum.
[3] E. Vicaut,et al. Penetrating Crohn Disease Is Not Associated With a Higher Risk of Recurrence After Surgery: A Prospective Nationwide Cohort Conducted by the Getaid Chirurgie Group. , 2019, Annals of surgery.
[4] W. Koltun,et al. Clinical and Genetic Factors Impact Time to Surgical Recurrence After Ileocolectomy for Crohn's Disease , 2019, Annals of surgery.
[5] Eun Soo Kim,et al. Risk Factors for Postoperative Recurrence in Korean Patients with Crohn’s Disease , 2019, Gut and liver.
[6] G. Kaplan,et al. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study , 2019, Gut.
[7] W. Bemelman. Evolving Role of IBD Surgery. , 2018, Journal of Crohn's & colitis.
[8] M. Regueiro,et al. ACG Clinical Guideline: Management of Crohn’s Disease in Adults , 2018, The American Journal of Gastroenterology.
[9] T. Shimosegawa,et al. Residual Lesions on Capsule Endoscopy Is Associated with Postoperative Clinical Recurrence in Patients with Crohn’s Disease , 2018, Digestive Diseases and Sciences.
[10] E. Vicaut,et al. DOP037 Postoperative anti-TNF therapy is associated with a significant reduction of both endoscopic and clinical recurrence following surgery for ileocolonic Crohn’s disease: results of a prospective nationwide cohort conducted by the GETAID chirurgie group , 2018 .
[11] A. Cheifetz,et al. Crohn Disease: Epidemiology, Diagnosis, and Management , 2017, Mayo Clinic proceedings.
[12] C. Buskens,et al. ECCO-ESCP Consensus on Surgery for Crohn's Disease. , 2017, Journal of Crohn's & colitis.
[13] C. Buskens,et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. , 2017, Journal of Crohn's & colitis.
[14] J. Zhong,et al. Potential model for differential diagnosis between Crohn's disease and primary intestinal lymphoma , 2016, World journal of gastroenterology.
[15] M. Regueiro,et al. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection. , 2016, Gastroenterology.
[16] Subrata Ghosh,et al. Cumulative Incidence of Second Intestinal Resection in Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Studies , 2014, The American Journal of Gastroenterology.
[17] F. Michelassi,et al. Surgical Treatment of Complex Small Bowel Crohn Disease , 2014, Annals of surgery.
[18] M. Mittlböck,et al. Surgical recurrence after primary ileocolic resection for Crohn’s disease , 2014, Techniques in Coloproctology.
[19] E. Savarino,et al. Adalimumab Is More Effective Than Azathioprine and Mesalamine at Preventing Postoperative Recurrence of Crohn's Disease: A Randomized Controlled Trial , 2013, The American Journal of Gastroenterology.
[20] Jia Ju Zheng,et al. Prevalence and incidence rates of Crohn's disease in mainland China: A meta‐analysis of 55 years of research , 2010, Journal of digestive diseases.
[21] W. Reinisch,et al. The Impact of Thiopurines on the Risk of Surgical Recurrence in Patients With Crohn's Disease After First Intestinal Surgery , 2010, The American Journal of Gastroenterology.
[22] M. Regueiro,et al. Infliximab prevents Crohn's disease recurrence after ileal resection. , 2009, Gastroenterology.
[23] Yan Yan,et al. Risk Factors for Surgical Recurrence after Ileocolic Resection of Crohn’s Disease , 2008, Diseases of the colon and rectum.
[24] A. Darzi,et al. A Meta-Analysis Comparing Incidence of Recurrence and Indication for Reoperation After Surgery for Perforating Versus Nonperforating Crohn's Disease , 2008, The American Journal of Gastroenterology.
[25] J. Satsangi,et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.
[26] Takayuki Yamamoto. Factors affecting recurrence after surgery for Crohn's disease. , 2005, World journal of gastroenterology.
[27] A. Sanabria,et al. Randomized controlled trial. , 2005, World journal of surgery.
[28] S. Hanauer,et al. Management of Crohn's Disease in Adults , 2001, The American Journal of Gastroenterology.
[29] G. Hellers,et al. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease , 2000, The British journal of surgery.
[30] H. Schumacher,et al. The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease. , 1996, Annals of surgery.
[31] P. Desreumaux,et al. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease. , 1995, The American journal of gastroenterology.
[32] T. Balestracci,et al. Primary and recurrent Crohn's disease. Experience with 1379 patients. , 1991, Annals of surgery.
[33] A. Peña,et al. Crohn's disease: risk of recurrence and reoperation in a defined population. , 1989, Gut.
[34] H. Tilg,et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management , 2017, Journal of Crohn's & colitis.
[35] T. Raffin,et al. Epidemiology, Diagnosis, and Management , 2015 .
[36] Subrata Ghosh,et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.